Stofwisselkracht in collaboration with Ride4Kids and Join4Energy granted Saskia Koene financial support for her project entitled "Preparations for a future clinical trial in children with the m.3243A>G mutation: a pilot study".In this project, preparations for a natural history study in this population will be performed by testing 10 selected outcomes measures in 10 patients with this mutation. The data provided by this study will be used to select clinically relevant and reliable endpoints for future studies.
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
RIMLS 25 years jubilee festival The Future is Yesterday3 October 2019
Together with more than 250 colleagues and alumni we celebrated 25 years of research into the molecular mechanisms of disease. During this exciting and informal event, we not only took a trip down memory lane, but also looked ahead to the next 25 years and beyond…...read more
New mitochondrial DNA maintenance disease uncovered1 October 2019
The group of Hans Spelbrink, theme Mitochondrial diseases, and colleagues, has identified and characterized mutations in the mtDNA maintenance gene SSBP1 in families with optic atrophy and foveopathy. This paper is now online in The Journal of Clinical Investigation.read more
Front cover Human Mutation21 August 2019
The MetaDome web server build to interpret genetic variants based on genetic tolerance and homologous protein domains is featured on the Cover of Human Mutation. MetaDome was developed by Laurens van de Wiel, Coos Baakman, Daan Gilissen, Joris Veltman, Gert Vriend and Christian Gilissen,read more
First results Nijmegen Exercise Study during the Four Days Marches25 July 2019
During the 103rd edition of the International Four Days Marches Nijmegen, Maria Hopman’s research team carried out two studies.read more
Handbook of biomarkers and precision medicine a new publication by Alain van Gool12 July 2019
Alain van Gool published a new handbook on biomarkers and applications in (pre)clinical drug development for precision medicine.read more